2026 NPPES data Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist NPI 1134520125 PHARM.D.
Verify on CMS →

ANI ALTOUNIAN, PHARM.D.

Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist in MISSION HILLS, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
453
Medicare Part D claims · 117 beneficiaries · Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist avg: 256
Generic prescribing
53%
generic claims · 47% brand-name · higher generic rates reduce patient out-of-pocket costs
What the federal data reveals: ANI ALTOUNIAN, PHARM.D. is a Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist ([object Object]) practicing in MISSION HILLS, California with a Medicare Part D prescribing footprint of 453 claims across 117 beneficiaries — 47% brand-name prescribing .

What stands out: ANI ALTOUNIAN, PHARM.D. filed 453 Medicare Part D claims in 2023 across MISSION HILLS, California. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

ANI ALTOUNIAN, PHARM.D. at a glance

Quality data not reported

NPI registry status

Active

Issued 09/09/2014

NPI 1134520125

Primary specialty

Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist

Mid-sized

12,377 US NPIs in this specialty

Medicare Part D claims

453 77% vs specialty avg

2023 prescription claims

Specialty avg: 256

Specialty distribution in California

How Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist compares to other specialties among California providers

California providers

Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist share within California

1. Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist share within California

Specialty board-certification context

Estimated specialty board-certified rate — Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist ABMS/AOA estimate

Est. board-certified rate (Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ANI ALTOUNIAN, PHARM.D. is a Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist provider practicing in MISSION HILLS, California, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: PHARM.D.. NPI: 1134520125. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

ANI ALTOUNIAN, PHARM.D. appears in the CMS NPPES registry as a Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist provider holding PHARM.D. credentials at 11165 SEPULVEDA BLVD, MISSION HILLS, CA, 91345, with a listed phone of (818) 837-5540. NPI 1134520125 was issued on 09/09/2014. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ALTOUNIAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 453 prescription claims written by this provider, covering 117 Medicare beneficiaries and totaling roughly $242K in drug spend, split 47% brand-name and 53% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist is a mid-sized specialty nationwide, with 12,377 enrolled providers across 55 states and an average of 256 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

11165 SEPULVEDA BLVD
MISSION HILLS, CA 91345

Provider Details

NPI 1134520125
Specialty Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist
Credentials PHARM.D.
Gender Female
NPI Issued 09/09/2014

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to ANI ALTOUNIAN, PHARM.D.. To verify ANI ALTOUNIAN, PHARM.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

ANI ALTOUNIAN, PHARM.D. — brand share 47.0%
Specialty average (est.)

47% brand-name claims vs 53% generic, on 453 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

453
Total Claims
$242K
Total Drug Cost
117
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,189
Total Day Supply
35,269
Brand vs Generic
47% brand / 53% generic
Brand Drug Cost
$234K
Generic Drug Cost
$7K

Patient Demographics

Average Patient Age
73.3 years
Avg HCC Risk Score
2.07
Gender Split
58% female / 42% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Warfarin Sodium
50
Trulicity
Dulaglutide
43
Glipizide
27
Metformin Hcl Er
Metformin Hcl
26
Glipizide Er
Glipizide
25
Metformin Hcl
24
Ozempic
Semaglutide
23
Farxiga
Dapagliflozin Propanediol
17
Atorvastatin Calcium
16
Enoxaparin Sodium
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Overview

How ANI ALTOUNIAN, PHARM.D. fits within the Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist landscape nationally.

12,377
Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Providers in US
55
States with Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist
256
Avg Claims per Provider

ANI ALTOUNIAN, PHARM.D.'s 453 claims are above the specialty average of 256.

Nearby Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as ALTOUNIAN.

Compare Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist nationally: see state-by-state distribution →

Frequently Asked Questions

What is ANI ALTOUNIAN, PHARM.D.'s specialty?
ANI ALTOUNIAN, PHARM.D. specializes in Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist and practices in MISSION HILLS, California. Credentials: PHARM.D..
How much does ANI ALTOUNIAN, PHARM.D. prescribe under Medicare Part D?
In 2023, ANI ALTOUNIAN, PHARM.D. wrote 453 Medicare Part D claims totaling $242K in drug costs for 117 beneficiaries.
Where is ANI ALTOUNIAN, PHARM.D. located?
ANI ALTOUNIAN, PHARM.D. is located at 11165 SEPULVEDA BLVD, MISSION HILLS, CA, 91345. Phone: (818) 837-5540.
What is ANI ALTOUNIAN, PHARM.D.'s NPI number?
ANI ALTOUNIAN, PHARM.D.'s National Provider Identifier (NPI) is 1134520125, issued on 09/09/2014.
Does ANI ALTOUNIAN, PHARM.D. prescribe more brand-name or generic drugs?
ANI ALTOUNIAN, PHARM.D.'s prescribing is 47% brand-name and 53% generic drugs by claim count, with $234K in brand drug costs.
How many Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist providers are there in the US?
There are 12,377 Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist providers across 55 states in the US. The average Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist provider writes 256 Medicare Part D claims per year.
What drugs does ANI ALTOUNIAN, PHARM.D. prescribe most often?
Based on 2023 Medicare Part D data, ANI ALTOUNIAN, PHARM.D.'s most frequently prescribed drugs include Warfarin Sodium, Trulicity, Glipizide. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ANI ALTOUNIAN, PHARM.D. accept Medicare?
ANI ALTOUNIAN, PHARM.D. appears in CMS Medicare data with 453 Part D claims and 117 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ANI ALTOUNIAN, PHARM.D.'s credentials?
ANI ALTOUNIAN, PHARM.D.'s NPI is 1134520125 with credentials PHARM.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology